Updated: March 28, 2026
Bimatoprost Shortage Update: What Patients Need to Know in 2026
Author
Peter Daggett

Summarize with AI
Is Bimatoprost still in shortage in 2026? Get the latest update on availability, pricing, alternatives, and how to find Bimatoprost in stock near you.
Bimatoprost in 2026: What's the Availability Situation?
If you rely on Bimatoprost eye drops to manage your glaucoma or ocular hypertension, you've probably noticed that filling your prescription hasn't always been smooth over the past year or two. Stock issues at pharmacies, back-ordered supplies, and confusing insurance requirements have left many patients wondering: is Bimatoprost in shortage?
Here's what we know heading into 2026 — and what you can do to make sure you don't miss a dose.
Is Bimatoprost Still in Shortage?
As of early 2026, Bimatoprost is not listed as an active shortage on the FDA's drug shortage database. That's the official status. However, the reality on the ground is more complicated.
Many patients and pharmacies across the country continue to report intermittent supply disruptions, particularly for the Bimatoprost 0.01% concentration (the strength used in brand-name Lumigan). These disruptions are not severe enough to trigger a formal FDA shortage listing, but they're real enough to cause headaches at the pharmacy counter.
The situation has improved since late 2025, when Amneal Pharmaceuticals received FDA approval for a generic version of Bimatoprost ophthalmic solution 0.01%. This added a new supplier to the market, which has helped ease some of the availability pressure. However, it takes time for new generic supply to fully distribute across all pharmacies nationwide.
Why Has Bimatoprost Been Hard to Find?
Several factors have contributed to the supply challenges:
Limited Generic Manufacturers
Ophthalmic solutions require specialized sterile manufacturing facilities. Not every generic drug company can produce eye drops, which means there are fewer suppliers for Bimatoprost compared to common oral medications. When even one manufacturer experiences a production delay, it can ripple through the entire supply chain.
Concentration-Specific Issues
Bimatoprost comes in two main concentrations for eye use: 0.01% and 0.03%. The 0.01% concentration — the current standard for Lumigan — has been more difficult to source than the 0.03% strength. If your prescription specifies one concentration and your pharmacy only has the other, you may not be able to fill it without a new prescription from your doctor.
Distribution Bottlenecks
Even when manufacturers have adequate supply, distribution to individual pharmacies can be uneven. Large chain pharmacies use automated ordering systems that may not prioritize lower-volume medications like Bimatoprost, while independent pharmacies may face allocation limits from wholesalers.
Insurance Formulary Shifts
Some insurance plans have shifted their preferred prostaglandin analog, moving Bimatoprost to a higher tier or requiring step therapy (trying Latanoprost first). This can reduce pharmacy demand for Bimatoprost, leading some locations to stop stocking it regularly — which then makes it harder to find when you do need it.
What Does Bimatoprost Cost in 2026?
Cost is an important part of the availability picture. Here's what patients can expect to pay:
- Brand-name Lumigan (0.01%): $200-$300+ per 2.5 mL bottle without insurance
- Generic Bimatoprost (0.03%): $50-$120 per bottle at retail cash price
- With discount cards (GoodRx, SingleCare): As low as $1-$57 for generic
- With insurance: Typically $10-$50 copay for generic; brand may cost more or require prior authorization
For a full breakdown of savings options, see our guide on how to save money on Bimatoprost in 2026.
New Options for Patients in 2026
There are some encouraging developments that may help patients going forward:
New Generic Approvals
The 2025 FDA approval of Amneal's generic Bimatoprost 0.01% has added a new supply source to the market. As this product continues to distribute nationwide, availability should improve throughout 2026.
The Durysta Implant
For patients with open-angle glaucoma who are tired of managing daily drops and dealing with availability issues, the Durysta intracameral implant offers a different approach. This tiny Bimatoprost implant is placed in the eye during a brief office procedure and releases medication gradually. It eliminates the need for daily drops and removes pharmacy availability from the equation entirely.
Durysta is covered by many insurance plans under medical benefits (not pharmacy benefits), and AbbVie offers a savings program to help with out-of-pocket costs.
Alternative Prostaglandin Analogs
If Bimatoprost remains difficult to find in your area, other prostaglandin analogs may be viable substitutes. Latanoprost (Xalatan) is widely available and affordable, Travoprost (Travatan Z) offers a gentler preservative system, and Tafluprost (Zioptan) is preservative-free. Learn more in our post on alternatives to Bimatoprost.
How to Find Bimatoprost in Stock Right Now
If you need to fill your prescription today, here's what to do:
- Use Medfinder to check which pharmacies near you have Bimatoprost available right now.
- Call independent pharmacies — they often have more flexible ordering and may carry stock that chains don't.
- Ask your pharmacy to order it — if your pharmacy can get it within a few days, ask them to place a special order.
- Check with your doctor about mail-order options or whether a different concentration is appropriate.
- Explore discount cards to expand which pharmacies you can afford to use.
For more tips, read our detailed guide on how to find Bimatoprost in stock near you.
Final Thoughts
The Bimatoprost supply situation in 2026 is improving, but it's not perfect. While there's no official FDA shortage, many patients still face real-world challenges at the pharmacy. The addition of new generic manufacturers, the Durysta implant option, and several effective alternative medications mean that you have more options than ever to keep your glaucoma treatment on track.
The most important thing is to not skip your medication. Untreated glaucoma can cause irreversible vision loss. If you can't find Bimatoprost, use the tools and alternatives available to you, and work closely with your eye doctor to ensure your treatment continues without interruption. For help finding a prescriber, check out our guide on how to find a doctor who can prescribe Bimatoprost near you.
Frequently Asked Questions
No. As of early 2026, Bimatoprost is not listed as an active shortage on the FDA's drug shortage database. However, many patients and pharmacies report intermittent supply disruptions, particularly for the 0.01% concentration. A new generic approval from Amneal in 2025 is helping improve availability.
Yes, the situation is expected to continue improving. The FDA approval of a new generic Bimatoprost 0.01% from Amneal Pharmaceuticals in late 2025 is adding supply to the market. As distribution expands throughout 2026, availability should become more consistent across pharmacies.
Use Medfinder (medfinder.com) to search nearby pharmacies, try independent pharmacies, ask your pharmacy to place a special order, or explore mail-order options. If you still can't find it, talk to your eye doctor about switching to an alternative like Latanoprost, Travoprost, or Tafluprost.
Generic Bimatoprost costs approximately $50 to $120 per bottle at retail cash price. With discount cards like GoodRx or SingleCare, prices can drop to as low as $1 to $57. Brand-name Lumigan can cost $200 to $300+ per bottle without insurance or savings programs.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsRelated articles
29,742 have already found their meds with Medfinder.
Start your search today.

![Who Has Vyvanse in Stock Near You? Find It Today [2026]](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2Fvur4atr4%2Fproduction%2F1079f61f167dcbc2ed5f1da17a0dcb0b7166357e-1024x1024.png%3Frect%3D0%2C256%2C1024%2C512%26w%3D400%26h%3D200%26auto%3Dformat&w=828&q=75)



